IP Library Granted Patent US 8,173,666
Granted Patent B2
US 8,173,666 · App. 12/558,395 · Granted May 8, 2012

Oligomer-opioid agonist conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,666
App. No.
12/558,395
Granted
May 8, 2012
Kind
B2
Abstract

The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Claims (24)

1. An opioid agonist compound of the formula

wherein

R 1 is methyl;

R 2 is OH;

R 3 is methyl;

R 4 is hydrogen;

Y 1 is oxygen; and

n is an integer from 1 to 30.

2. The compound of claim 1 , wherein n is an integer from 1 to 10.

3. The compound of claim 2 , wherein n is 1.

4. The compound of claim 2 , wherein n is 2.

5. The compound of claim 2 , wherein n is 3.

6. The compound of claim 2 , wherein n is 4.

7. The compound of claim 2 , wherein n is 5.

8. The compound of claim 2 , wherein n is 6.

9. The compound of claim 2 , wherein n is 7.

10. The compound of claim 2 , wherein n is 8.

11. The compound of claim 2 , wherein n is 9.

12. An opioid agonist compound of the formula

wherein n is an integer from 1 to 30.

13. A composition comprising a compound of claim 1 , and optionally, a pharmaceutically acceptable excipient.

14. The composition of claim 13 , wherein the composition is suitable for oral administration.

15. A composition of matter comprising a compound of claim 1 , wherein the compound is present in a dosage form.

16. A method of treating pain in a patient, comprising administering a therapeutically effective amount of a compound of claim 1 to the patient in need thereof.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2023
From: INHERIS BIOPHARMA, INC.
To: NEKTAR THERAPEUTICS
Reel/Frame 062313/0501 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: INHERIS BIOPHARMA, INC.
Reel/Frame 052435/0062 →
CHANGE OF NAME Recorded Nov 15, 2019
From: INHERIS PHARMACEUTICALS, INC.
To: INHERIS BIOPHARMA, INC.
Reel/Frame 051038/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: NEKTAR THERAPEUTICS
To: INHERIS PHARMACEUTICALS, INC.
Reel/Frame 050846/0461 →
SECURITY INTEREST Recorded Oct 28, 2019
From: INHERIS PHARMACEUTICALS, INC.
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 050846/0940 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2009
From: RIGGS-SAUTHIER, JENNIFER; DENG, BO-LIANG; RILEY, TIMOTHY A.
To: NEKTAR THERAPEUTICS
Reel/Frame 023484/0664 →